<?xml version="1.0" encoding="UTF-8"?>
<notes id="n1">
 <title>Notes</title>
 <p>
  <bold>
   <italic>Acknowledgments.</italic>
  </bold> We gratefully acknowledge the contributions of Amanda Adler, MS, Seattle Children’s Research Institute; Xuan Qin, PhD, Seattle Children’s Hospital Department of Laboratory Medicine; Arnold S. Monto, MD, University of Michigan School of Public Health; In Young Yoo, MD, Department of Laboratory Medicine and Genetics, Samsung Medical Center; and Jessica Morris, MPH, Fred Hutchinson Cancer Research Center to this manuscript.
 </p>
 <p>
  <bold>
   <italic>Financial support</italic>
  </bold>. This work was supported by the National Institutes of Health (K23AI139385 to C. O.).
 </p>
 <p>
  <bold>
   <italic>Potential conflicts of interest.</italic>
  </bold> J. A. E. is a consultant for Sanofi Pasteur and Meissa Vaccines and has received research support from GSK, Merck, Medimmune, and Novavax. E. T. M. is a consultant for Pfizer and has received research support from Merck. All remaining authors: No reported conflicts of interest. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
 </p>
</notes>
